A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of about 20 percent this year, compared with an average of 16 percent across all sectors.”
This article focuses on IPOs for health biotech companies, but there is also a lot going on right now in investment in industrial biotechnology. BIO’s 2013 World Congress on Industrial Biotechnology this June in Montreal will feature Clean Tech Investor Sessions beginning with an investor panel discussion and continuing with company presentations on their technology development and business models.
The Investor Panel Discussion on Monday June 17 is comprised of leading investors who will discuss investment opportunities and funding sources to help identify the right funding for clean tech businesses. The discussion will be moderated by Taite McDonald, Senior Advisor, Energy & Clean Technology Government Initiatives, Wilson Sonsini Goodrich & Rosati. Expert panelists include Dirk Den Ouden, Senior Manager, Kempen & Co Corporate Finance; Felipe Pereira, Sector Manager, AIB, Department of Chemical Industry, BNDES; Josko Bobanovic, Partner, Green Chemistry and Bioenergy, Sofinnova Partners; Neil Cameron, PhD, Investment Director, Emerald Technology Ventures; and Thomas J. Erickson, Co-President and Director, First Green Partners.
That discussion kicks off more than a dozen investor sessions over the next two days. CEOs and COOs from emerging industrial biotechnology companies seeking investment and partnering opportunities will make formal 25-minute presentations showcasing their new technologies, accomplishments, milestones, value proposition and business case. These sessions are designed to spur investment in companies seeking to raise money.
“Presenting companies will cover advanced biofuels, renewable chemical platforms and biomass conversion technologies to cheap and sustainable sugar sourcing,” said Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section. “Companies will showcase their innovative technologies highlighting the industry’s growth, and the importance of industrial and environmental biotechnology for generating green jobs, making greener products and cleaner processes all aimed at building a biobased economy.”
Many innovative companies will make their case over the two days of investor sessions. Agrivida is developing proprietary crops and processes to transform the economics of producing renewable chemicals, fuels and bioproducts from non-food cellulosic biomass. The company’s patented approach is designed to provide an integrated solution for delivering the lowest-cost sugars that are essential for industrial bioproducts.
Evolva’s mission is to discover and provide innovative, sustainable ingredients for health, nutrition and wellness. Evolva uses biosynthetic and evolutionary technologies to create and optimize small molecule compounds and their production routes.
ForeLight has developed the fastest, most efficient photobioreactor on the planet. They have created a highly efficient, cost-effective system that will be a valuable resource for existing industries – even as it opens the door for new applications.
Terviva has created an agriculture-based system to produce bio-products. By accelerating the commercialization time of a novel tree crop from decades to only a few years, they are simultaneously solving two problems: the increasing amount of non-arable land and the demand for sustainably produced bio-products.
These are just some of the companies looking to showcase the latest and greatest in innovation in industrial biotech and secure investment in their businesses. For a full list of presenting companies, click here.